Beneficial ownership — 13D / 13G
87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| Broad Run Investment Management, LLC | ECPG Encore Capital Group Inc | 13G/A | 4.8% | Dec 31, 2023 | 2y |
| HPS Investment Partners, LLC | XPRO Expro Ltd | 13G/A | 4% | Dec 31, 2023 | 2y |
| Fourthstone LLC | CHMG Chemung Financial Corp | 13G | 8.07% | Dec 31, 2023 | 2y |
| GLAZER CAPITAL, LLC | AFAR Aura FAT Projects Acquisition Corp Class A Ordinary Shares | 13G/A | 14.35% | Dec 31, 2023 | 2y |
| RICE HALL JAMES & ASSOCIATES, LLC | TRAK ReposiTrak, Inc. | 13G/A | 5.6% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | GAQ Generation Asia I Acquisition Limited Class A Ordinary Shares | 13G/A | 2.99% | Dec 31, 2023 | 2y |
| GMB Culture Communication Co., Ltd. | EPOW E-Power Inc. | 13G | 9.97% | Dec 31, 2023 | 2y |
| Lytton, Laurence W. | XGN Exagen Inc. | 13G/A | 6.8% | Dec 31, 2023 | 2y |
| Beehouse, LLC | AAWH Ascend Wellness Holdings, Inc. | 13G/A | 8.3% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | GMDA Gamida Cell Ltd. Ordinary Shares | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| MARSHALL WACE, LLP | APGB Apollo Strategic Growth Capital II | 13G/A | 0% | Dec 31, 2023 | 2y |
| Kerry Propper | FRXB Forest Road Acquisition Corp. II | 13G/A | 0% | Dec 31, 2023 | 2y |
| Theodore Walker Cheng-De King | FEDU Four Seasons Education (Cayman) Inc. | 13G/A | 12.41% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | FLD Fold Holdings, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | MGYR Magyar Bancorp, Inc. | 13G/A | 8.74% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | ZYME Zymeworks Inc. | 13G/A | 1.5% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | MDB MongoDB, Inc. | 13G/A | 4.3% | Dec 31, 2023 | 2y |
| Shaolin Capital Management LLC | BFAC Battery Future Acquisition Corp. | 13G/A | 5.09% | Dec 31, 2023 | 2y |
| CVI Investments, Inc. | EOSE Eos Energy Enterprises, Inc. | 13G/A | 4.9% | Dec 31, 2023 | 2y |
| Kynam Capital Management, LP | OLMA Olema Oncology, Inc. | 13G/A | 0% | Dec 31, 2023 | 2y |
| Radcliffe Capital Management, L.P. | LOCC Live Oak Crestview Climate Acquisition Corp. | 13G/A | 0% | Dec 31, 2023 | 2y |
| FRONTIER CAPITAL MANAGEMENT CO.,LLC | SRI Stoneridge Inc | 13G/A | 7.98% | Dec 31, 2023 | 2y |
| ORBIMED ADVISORS LLC | NPCE NeuroPace Inc | 13G/A | 15.2% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | RVMD Revolution Medicines, Inc. | 13G/A | 0.1% | Dec 31, 2023 | 2y |
| Oasis Management Co Ltd. | CO Global Cord Blood Corporation | 13G/A | 9.91% | Dec 31, 2023 | 2y |
| Yiheng Capital Management, L.P. | ACMR ACM Research, Inc. | 13G/A | 9.65% | Dec 31, 2023 | 2y |
| Venrock Healthcare Capital Partners III, L.P. | ABVX Abivax S.A. | 13G/A | 5.7% | Dec 31, 2023 | 2y |
| TURTLE CREEK ASSET MANAGEMENT INC. | JELD JELD-WEN Holding, Inc. | 13G/A | 16.4% | Dec 31, 2023 | 2y |
| First Trust Capital Management L.P. | LCAA L Catterton Asia Acquisition Corp Class A Ordinary Shares | 13G | 8.77% | Dec 31, 2023 | 2y |
| EcoR1 Capital, LLC | ZYME Zymeworks Inc. | 13G/A | 19.99% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | DAY Dayforce, Inc. | 13G/A | 12.4% | Dec 31, 2023 | 2y |
| Rosalind Advisors, Inc. | NSPR InspireMD, Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| ALLIANCEBERNSTEIN L.P. | PNBK Patriot National Bancorp Inc | 13G/A | 9.8% | Dec 31, 2023 | 2y |
| Sculptor Capital LP | DISA Disruptive Acquisition Corporation I Class A Ordinary Shares | 13G/A | 17.53% | Dec 31, 2023 | 2y |
| CADIAN CAPITAL MANAGEMENT, LP | CRTO Criteo S.A. | 13G | 7.5% | Dec 31, 2023 | 2y |
| John A. Kryzanowski | SYBX Synlogic, Inc. | 13G/A | 9.51% | Dec 31, 2023 | 2y |
| PRICE T ROWE ASSOCIATES INC /MD/ | MOH Molina Healthcare, Inc. | 13G | 7.2% | Dec 31, 2023 | 2y |
| Clal Insurance Enterprises Holdings Ltd | ALLT Allot Ltd. | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| METEORA CAPITAL, LLC | CSTAF Constellation Acquisition Corp I | 13G | 6.54% | Dec 31, 2023 | 2y |
| Walleye Capital LLC | NIXX Nixxy, Inc. | 13G | 7.75% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | FNRN First Northern Community Bancorp | 13G/A | 5.69% | Dec 31, 2023 | 2y |
| Blue Ocean Sponsor LLC | BOCN Blue Ocean Acquisition Corp Class A Ordinary Shares | 13G/A | 41.4% | Dec 31, 2023 | 2y |
| Indaba Capital Management, L.P. | LAB Standard Biotools Inc. | 13G/A | 9.9% | Dec 31, 2023 | 2y |
| PERCEPTIVE ADVISORS LLC | ACRV Acrivon Therapeutics, Inc. | 13G/A | 13.6% | Dec 31, 2023 | 2y |
| 272 Capital LP | HBIO Harvard Bioscience Inc | 13G/A | 6.9% | Dec 31, 2023 | 2y |
| GREAT POINT PARTNERS LLC | AVTX Avalo Therapeutics, Inc. | 13G/A | 0.26% | Dec 31, 2023 | 2y |
| Weiss Multi-Strategy Advisers LLC | SCOR Comscore, Inc. | 13G/A | 9.48% | Dec 31, 2023 | 2y |
| Caledonia (Private) Investments Pty Ltd | LAWIL Light & Wonder, Inc. | 13G/A | 9.47% | Dec 31, 2023 | 2y |
| Altai Capital Management, L.P. | DMRC Digimarc Corp | 13G/A | 14.1% | Dec 31, 2023 | 2y |
| M3 Funds, LLC | BSBK Bogota Financial Corp. | 13G/A | 3.76% | Dec 31, 2023 | 2y |